Literature DB >> 6154315

Inhibition of cell motility by interferon.

D Brouty-Boyé, B R Zetter.   

Abstract

Interferon derived from human leukocytes, human fibroblasts, and mouse fibroblasts was found to inhibit the motility of cultured cells. It inhibits the tumor-induced motility of capillary endothelial cells as well as the spontaneous migration of other cell types. The ability of a given preparation of interferon to inhibit the motility of a given cell type is proportional to its antiviral activity in that particular cell type. Antiserum to human leukocyte interferon neutralizes both the motility-inhibitory activity and the antiviral activity of this preparation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154315     DOI: 10.1126/science.6154315

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  46 in total

Review 1.  Interferons as antiangiogenic agents.

Authors:  Daniel J Lindner
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

Review 2.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

3.  Intralesional administration of interferon A for the management of severe haemangiomas.

Authors:  C Kaselas; G Tsikopoulos; G Papouis; V Kaselas
Journal:  Pediatr Surg Int       Date:  2006-12-15       Impact factor: 1.827

4.  Inhibition of wound healing in mice by local interferon alpha/beta injection.

Authors:  A J Stout; I Gresser; W D Thompson
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

5.  Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.

Authors:  J N Kirkpatrick; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

Review 6.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

Review 7.  Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases.

Authors:  J E O'Connell; G J Kearns
Journal:  Ir J Med Sci       Date:  2012-10-26       Impact factor: 1.568

8.  Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.

Authors:  J Frederic Mushinski; Phuongmai Nguyen; Lisa M Stevens; Chand Khanna; Sunmin Lee; Eun Joo Chung; Min-Jung Lee; Yeong Sang Kim; W Marston Linehan; Michel A Horisberger; Jane B Trepel
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

9.  Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood.

Authors:  R R Ricketts; R M Hatley; B J Corden; H Sabio; C G Howell
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

10.  Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon.

Authors:  M Ueda; Y Mishima; M Mojamdar; M Ichihashi; M Kita; T Kishida
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.